<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: breast tumor</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Study finds new drug target for metastatic breast cancer</title>
   	 <description>Research led by Dr. Suresh Alahari, Professor of Biochemistry and Molecular Biology at LSU Health Sciences Center New Orleans, is the first to report that two specific tumor suppressor genes work in concert to inhibit the growth and spread of breast tumor cells to the lungs. The research is published this week online in the Journal of Biological Chemistry.</description>
     <link>http://medicalxpress.com/news/2013-04-drug-metastatic-breast-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 11 Apr 2013 11:14:20 EST</pubDate>
	 <guid isPermaLink="false">news284897653</guid>
	 
</item>
<item>
     <title>Signature of circulating breast tumor cells that spread to the brain found</title>
   	 <description>Some breast tumor circulating cells in the bloodstream are marked by a constellation of biomarkers that identify them as those destined to seed the brain with a deadly spread of cancer, said researchers led by those at Baylor College of Medicine in a report that appears online in the journal Science Translational Medicine.</description>
     <link>http://medicalxpress.com/news/2013-04-signature-circulating-breast-tumor-cells.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 10 Apr 2013 14:00:02 EST</pubDate>
	 <guid isPermaLink="false">news284818141</guid>
	 
</item>
<item>
     <title>Scientists find promising new approach to preventing progression of breast cancer</title>
   	 <description>February 15, 2013 – Doctors currently struggle to determine whether a breast tumor is likely to shift into an aggressive, life-threatening mode—an issue with profound implications for treatment. Now a group from The Scripps Research Institute (TSRI) has identified a mechanism through which mitochondria, the powerhouses of a cell, control tumor aggressiveness. Based on their findings, the team developed a simple treatment that inhibits cancer progression and prolongs life when tested in mice.</description>
     <link>http://medicalxpress.com/news/2013-02-scientists-approach-breast-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 15 Feb 2013 13:07:50 EST</pubDate>
	 <guid isPermaLink="false">news280156049</guid>
	 
</item>
<item>
     <title>Research improving breast cancer treatment by targeting tumor initiating cells</title>
   	 <description>A Kansas State University professor's research on breast cancer stem cells may help improve survival rates by preventing cancer recurrence and metastasis—the major causes of death among breast cancer patients.</description>
     <link>http://medicalxpress.com/news/2013-02-breast-cancer-treatment-tumor-cells.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 13 Feb 2013 11:30:04 EST</pubDate>
	 <guid isPermaLink="false">news279973961</guid>
	 
</item>
<item>
     <title>Study provides new drug target for Her-2 related breast cancer</title>
   	 <description>Research led by Dr. Suresh Alahari, the Fred Brazda Professor of Biochemistry and Molecular Biology at LSU Health Sciences Center New Orleans and its Stanley S. Scott Cancer Center, details exactly how the Her2 cancer gene promotes the progression and spread of breast cancer cells. The inactivation of a tumor suppression gene called Nischarin is among the mechanisms identified. The findings provide a new therapeutic target to block the function of Her2. The research was published in Cancer Research, OnlineFirst on January 21, 2013.</description>
     <link>http://medicalxpress.com/news/2013-01-drug-her-breast-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 22 Jan 2013 13:12:49 EST</pubDate>
	 <guid isPermaLink="false">news278082689</guid>
	 
</item>
<item>
     <title>Researchers discover novel role of the NEDD9 gene in early stages of breast cancer</title>
   	 <description>Breast cancer is the second leading cause of cancer deaths among women in the United States. Many of these deaths occur when there is an initial diagnosis of invasive or metastatic disease. A protein called NEDD9—which regulates cell migration, division and survival—has been linked to tumor invasion and metastasis in a variety of cancers. Researchers at Fox Chase Cancer Center have now shown that NEDD9 plays a surprising role in the early stages of breast tumor development by controlling the growth of progenitor cells that give rise to tumors. The findings, published in the journal Oncogene on January 14, 2013, could lead to personalized treatment strategies for women with breast cancer based on the levels of NEDD9 in their tumors.</description>
     <link>http://medicalxpress.com/news/2013-01-role-nedd9-gene-early-stages.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 14 Jan 2013 13:08:36 EST</pubDate>
	 <guid isPermaLink="false">news277391310</guid>
	 
</item>
<item>
     <title>Laser-light testing of breast tumor fiber patterns helps show whose cancer is spreading</title>
   	 <description>Using advanced microscopes equipped with tissue-penetrating laser light, cancer imaging experts at Johns Hopkins have developed a promising, new way to accurately analyze the distinctive patterns of ultra-thin collagen fibers in breast tumor tissue samples and to help tell if the cancer has spread.</description>
     <link>http://medicalxpress.com/news/2012-11-laser-light-breast-tumor-fiber-patterns.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 01 Nov 2012 14:30:15 EST</pubDate>
	 <guid isPermaLink="false">news270999007</guid>
	 
</item>
<item>
     <title>Socioeconomic disadvantage linked to breast cancer tumor disparity</title>
   	 <description>Racial and ethnic disparities in breast tumor aggressiveness might be explained by social factors that influence the developing tumor and place those in disadvantaged groups at higher risk for aggressive breast cancer, according to data presented at the Fifth AACR Conference on The Science of Cancer Health Disparities, held here Oct. 27-30, 2012.</description>
     <link>http://medicalxpress.com/news/2012-10-socioeconomic-disadvantage-linked-breast-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 30 Oct 2012 06:30:45 EST</pubDate>
	 <guid isPermaLink="false">news270797388</guid>
	 
</item>
<item>
     <title>Outcomes similar with partial, whole breast irradiation</title>
   	 <description>(HealthDay)—Accelerated partial breast irradiation (APBI) yields five-year clinical outcomes and patterns of failure similar to those achieved with whole breast irradiation (WBI), with excellent three-year survival for women who develop an ipsilateral breast tumor recurrence (IBTR), according to a study published in the Sept. 1 issue of Cancer.</description>
     <link>http://medicalxpress.com/news/2012-08-outcomes-similar-partial-breast-irradiation.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 24 Aug 2012 14:10:01 EST</pubDate>
	 <guid isPermaLink="false">news265033685</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/outcomessimi.jpg" width="90" height="90" />
</item>
<item>
     <title>Older women may not benefit from radiotherapy after breast surgery</title>
   	 <description>A Rhode Island Hospital radiation oncologist says in a new editorial that research exploring the impact of radiotherapy in older women with low risk of breast cancer recurrence has little effect on actual clinical decisions. The editorial written by David E. Wazer, M.D., chief of the department of radiation oncology, is published in the current issue of the Journal of Clinical Oncology.</description>
     <link>http://medicalxpress.com/news/2012-08-older-women-benefit-radiotherapy-breast.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 21 Aug 2012 11:49:46 EST</pubDate>
	 <guid isPermaLink="false">news264768580</guid>
	 
</item>
<item>
     <title>Researchers find potential cancer roadblock</title>
   	 <description>By identifying a key protein that tells certain breast cancer cells when and how to move, researchers at Michigan State University hope to better understand the process by which breast cancer spreads, or metastasizes.</description>
     <link>http://medicalxpress.com/news/2012-08-potential-cancer-roadblock.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 01 Aug 2012 14:20:01 EST</pubDate>
	 <guid isPermaLink="false">news263048767</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/26-researchersf.jpg" width="90" height="90" />
</item>
<item>
     <title>Skin contact breast tumor detection</title>
   	 <description>A simple and cost effective imaging device for breast tumor detection based on a flexible and wearable antenna system has been developed by researchers at the Indiana University &amp;#150; Purdue University Indianapolis. </description>
     <link>http://medicalxpress.com/news/2012-06-skin-contact-breast-tumor.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 29 Jun 2012 12:40:01 EST</pubDate>
	 <guid isPermaLink="false">news260191763</guid>
	 
</item>
<item>
     <title>Breast MRI helps predict chemotherapy's effectiveness</title>
   	 <description>Magnetic resonance imaging (MRI) provides an indication of a breast tumor's response to pre-surgical chemotherapy significantly earlier than possible through clinical examination, according to a new study published online in the journal Radiology.</description>
     <link>http://medicalxpress.com/news/2012-05-breast-mri-chemotherapy-effectiveness.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 23 May 2012 04:40:02 EST</pubDate>
	 <guid isPermaLink="false">news256966083</guid>
	 
</item>
<item>
     <title>Margin threshold for women with ductal carcinoma in situ</title>
   	 <description>Negative surgical margins should be attained for ductal carcinoma in situ (DCIS) patients after breast-conserving surgery (BCS) regardless of radiotherapy, and surgeons should attempt to reach wide negative margins in their first attempt within cosmetic restraint according to a study published March 22 in the Journal of the National Cancer Institute.</description>
     <link>http://medicalxpress.com/news/2012-03-margin-threshold-women-ductal-carcinoma.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 22 Mar 2012 16:00:01 EST</pubDate>
	 <guid isPermaLink="false">news251637087</guid>
	 
</item>
<item>
     <title>'Obscurins' in breast tissue may help physicians predict and detect breast cancer</title>
   	 <description>A new discovery published online in The FASEB Journal may lead to a new tool to help physicians assess breast cancer risk as well as diagnose the disease. In the report, researchers from Johns Hopkins University and the University of Maryland, explain how proteins, called &quot;obscurins,&quot; once believed to only be in muscle cells, act as &quot;tumor suppressor genes&quot; in the breast. When their expression is lost, or their genes mutated in epithelial cells of the breast, cancer develops. It promises to tell physicians how breast cancer develops and/or how likely it is.</description>
     <link>http://medicalxpress.com/news/2012-03-obscurins-breast-tissue-physicians-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 21 Mar 2012 14:36:57 EST</pubDate>
	 <guid isPermaLink="false">news251559405</guid>
	 
</item>
<item>
     <title>New point of attack for breast cancer with poor prognosis</title>
   	 <description>(Medical Xpress) -- Scientists from the Friedrich Miescher Institute for Biomedical Research describe how the protein phosphatase SHP2 promotes breast cancer with poor prognosis. As they report in the latest issue of Nature Medicine, SHP2 is necessary for the maintenance of the few tumor initiating cells (TICs) in a breast tumor. These cells are thought to sustain the growth of the tumor, promote metastasis and lead to relapses.</description>
     <link>http://medicalxpress.com/news/2012-03-breast-cancer-poor-prognosis.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 05 Mar 2012 08:56:18 EST</pubDate>
	 <guid isPermaLink="false">news250160154</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/newpointofat.jpg" width="90" height="90" />
</item>
<item>
     <title>Some breast cancer spread may be triggered by a protein, study shows</title>
   	 <description>Cancers rarely are deadly unless they evolve the ability to grow beyond the tissues in which they first arise. Normally, cells -- even early-stage tumor cells -- are tethered to scaffolding that helps to restrain any destructive tendencies. But scientists from the University of Helsinki, Finland, and from UCSF have identified a cleaver-wielding protein that frees some tumor cells, allowing them to further misbehave.</description>
     <link>http://medicalxpress.com/news/2012-01-breast-cancer-triggered-protein.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 17 Jan 2012 10:24:05 EST</pubDate>
	 <guid isPermaLink="false">news246018238</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/somebreastca.jpg" width="90" height="81" />
</item>
<item>
     <title>ISG15: A novel therapeutic target to slow breast cancer cell motility</title>
   	 <description>Interferon-stimulated gene 15 (ISG15), a ubiquitin like protein, is highly elevated in a variety of cancers including breast cancer. How the elevated ISG15 pathway contributes to tumorigenic phenotypes remains unclear and is the subject of a study published in the January 2012 issue of Experimental Biology and Medicine. </description>
     <link>http://medicalxpress.com/news/2012-01-isg15-therapeutic-breast-cancer-cell.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 11 Jan 2012 16:26:47 EST</pubDate>
	 <guid isPermaLink="false">news245521503</guid>
	 
</item>
<item>
     <title>Breast cancers at lower-risk detected with widespread use of mammograms</title>
   	 <description>As a woman ages, her chances of being diagnosed with a lower-risk breast tumor increase, according to a novel study led by UCSF which found that for women over 50, a substantial number of cancers detected by mammograms have good prognoses.</description>
     <link>http://medicalxpress.com/news/2011-12-breast-cancers-lower-risk-widespread-mammograms.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 19 Dec 2011 12:34:16 EST</pubDate>
	 <guid isPermaLink="false">news243520432</guid>
	 
</item>
<item>
     <title>New protein may suppress breast cancer growth</title>
   	 <description>Research led by Dr. Suresh Alahari, the Fred Brazda Professor of Biochemistry and Molecular Biology at LSU Health Sciences Center New Orleans and its Stanley S. Scott Cancer Center, has found that a protein discovered by his laboratory can inhibit the growth of breast cancer cells. The research will be published September 14, 2011 online in the Journal of the National Cancer Institute.</description>
     <link>http://medicalxpress.com/news/2011-09-protein-suppress-breast-cancer-growth.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 14 Sep 2011 16:30:53 EST</pubDate>
	 <guid isPermaLink="false">news235236613</guid>
	 
</item>
<item>
     <title>New genome profiling technique identifies weak points in breast cancer cells</title>
   	 <description>New research published in Cancer Discovery, the newest journal of the American Association for Cancer Research, details a large-scale project in genetic profiling that has identified many of the weak points in breast tumor cells. </description>
     <link>http://medicalxpress.com/news/2011-08-genome-profiling-technique-weak-breast.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 03 Aug 2011 13:30:02 EST</pubDate>
	 <guid isPermaLink="false">news231595901</guid>
	 
</item>
<item>
     <title>Gamma imaging provides superior tumor detection for dense breasts</title>
   	 <description>A study revealed at SNM's 58th Annual Meeting is comparing the breast-tumor detection capabilities of two very different imaging technologies&amp;#151;breast-specific gamma imaging (BSGI), which provides functional images of breast physiology, and ultrasound&amp;#151;for women with complex breast imaging cases that require further evaluation. Many women who have dense breast tissue (radiodense breasts) are difficult to image using mammography, currently the gold standard of breast imaging. For women whose mammograms are not clear enough to determine whether cancer is present, support methods such as BSGI and ultrasound are used to answer any remaining diagnostic questions.</description>
     <link>http://medicalxpress.com/news/2011-06-gamma-imaging-superior-tumor-dense.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 06 Jun 2011 13:08:03 EST</pubDate>
	 <guid isPermaLink="false">news226584475</guid>
	 
</item>
<item>
     <title>Parsley, celery carry crucial component for fight against breast cancer, researcher finds</title>
   	 <description>Parsley is usually used as a decorative accent to a scrumptious meal, but don't set it aside just yet. In a new study, a University of Missouri researcher has found that a compound in parsley and other plant products, including fruits and nuts, can stop certain breast cancer tumor cells from multiplying and growing. The study was published recently in Cancer Prevention Research.</description>
     <link>http://medicalxpress.com/news/2011-05-parsley-celery-crucial-component-breast.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 09 May 2011 12:30:30 EST</pubDate>
	 <guid isPermaLink="false">news224162997</guid>
	 
</item>


</channel>
</rss>
